Dual Use Science and Technology (DUST)

Manager: The Undersecretary of Defense (Science and Technology)

Summary: A contract program for industry under which the performing company provides at least half the project's total cost.

Program Process:

  • Services develop topics for solicitation, commit matching funds
  • Office of Undersecretary solicits proposals
  • Office of Undersecretary evaluates proposals, selects awardees
  • Funding contributions for approved projects
    • 50% from company
    • 25% from Office of Undersecretary
    • 25% from service organization proposing topic

Technology Maturity Level: Applied and advanced projects at the 6.2/6.3 levels

Award Size: Up to $5M.

Program Size: $40M in FY02.

Format Requirements for Topic Submission: USAMRMC submits relatively short (one to two pages) narratives describing proposed Phase I topics.

Criteria for Selecting Topics:

  • Military relevance
  • Commercial appeal

Format requirements for topic submission: TBD

Criteria for Selecting Proposals:

  • Military relevance
  • Technical merit
  • Management plan

USAMRMC Participation:

  • Topic development
  • Proposal review
  • Contract monitoring


USAMRMC topic proposals to program manager Jan
Public solicitation opens May
Pre-proposals from applicants June
Full Proposals Aug
Awards announced Oct

USAMRMC Recent History: significant participation, but may be limited by availability of funds.

Comments: Program has high visibility with Congress, financed by a tax on all 6.1 – 6.3 research funds.


  • Development of a Live Attenuated Vaccine for the Prevention of ETEC Diarrhea. (Non-Federal Participant: Peptide Therapeutics Group plc, Cambridge, England.)
  • Development of a Subunit Vaccine for the Prevention of Campylobacter Disease. (Non-Federal Participants: OraVax Inc., Cambridge, MA and Peptide Therapeutics Group plc, Cambridge, England)
  • Development of a Dengue Virus Tetravalent DNA Vaccine Using LAMP and Controlled Release Technologies. (Non-Federal Participants: Cytec Industries, West Paterson, NJ.)
  • The Application of Electrode Arrays for the Development of a Rapid,
  • Multiplexed Diagnostics System for Biological Warfare and Infectious Disease. (Non-Federal Participants: Nanogen Inc., San Diego, CA.)
Last Modified Date: 12-Jan-2010